Shariah compliance overview
HalalGenmab A/S (GNMSF) is currently classified as Halal by Akinda Shariah screening (AAOIFI-aligned methodology).
About Genmab A/S
Genmab A/S, founded in 1999 and based in Copenhagen, Denmark, is a biopharmaceutical firm focused on developing antibody-based therapeutics to treat cancer and a range of other diseases.
Genmab A/S (GNMSF) operates in the Healthcare sector, in the Biotechnology industry.
Why it is halal: it passes all three AAOIFI screens. Non-compliant revenue is 3.58% (limit 5%), interest-bearing debt is 7.69% (limit 30%) and interest-bearing securities and assets are 2.43% (limit 30%).
If you hold GNMSF, give 3.58% of the dividends you receive to charity to purify the non-compliant share of its income.
- Business Activity
- 3.58%Limit 5%Pass
- Interest-bearing debt
- 7.69%Limit 30%Pass
- Interest-bearing securities and assets
- 2.43%Limit 30%Pass
- Dividend purification
- 3.58%Share of dividends to give to charityPurification calculator
Last updated: Oct 22, 2026 · Screening is informational and not a fatwa. Consult a qualified scholar for personal guidance.
Please login to access this content
Please login to access this content
Please login to access this content
Company Profile
Please login to access this content
Frequently asked questions
Quick answers about Genmab A/S (GNMSF). Current Akinda screening label: Halal.
